accreditation and certification

intended audience

This activity was developed for physicians, nurse practitioners, nurses, pharmacists and other health care professionals caring for low birth weight infants with PDAs.

statement of need

It is evident that a diversity of opinion and practice patterns exist around the diagnosis and treatment of PDA. Though rapid and accurate diagnosis can lead to optimized treatment results and minimized complications, diagnosis is often delayed for a variety of reasons. Treatment is often based more on institutional practice than individual patient condition and risk factors. This activity will look at factors to be considered in choosing optimal treatment protocols for low birth weight infants with PDAs.

learning objectives

Upon completion of this activity, participants should be better able to:

Utilize appropriate tools and information to provide a timely and accurate

diagnosis of PDA

Examine various treatment options including conventional care, surgical,

and medical management with cyclooxygenase inhibitors

Provide optimal management of patients with PDA based on various factors

Incorporate data on timing, dosing, safety and efficacy into treatment planning

for specific patients

Pharmacists will also be better able to assess the differences between pharmacologic treatment options to enhance patient health.

Nurses will also have a better understanding of various treatment protocols to assist both patients and their families through the recovery process.

accreditation and certification

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Annenberg Center for Health Sciences at Eisenhower and Akita Biomedical Consulting. The Annenberg Center is accredited by the ACCME to provide continuing medical education for physicians.

The Annenberg Center designates this educational activity for a maximum of 1 AMA PRA Category 1 Credittm. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program has been developed according to the ACPE Criteria for Quality and is assigned ACPE Universal Program #797-999-08-004-H04-P. This program is designated for up to 1 contact hour (0.1 CEUs) of continuing pharmacy education credit.

Annenberg Center for Health Sciences is approved as a provider of nurse practitioner continuing education by the American Academy of Nurse Practitioners. Provider # 040207. The Annenberg Center designates this program for 1 contact hour of continuing education.

Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
A maximum of 1 contact hour may be earned for successful completion of this activity.

There is no charge for this activity. Statements of Credit will be mailed 4-6 weeks following activity participation, upon completion and return of the evaluation form to the Annenberg Center for Health Sciences (#4637), 39000 Bob Hope Drive, Rancho Mirage, CA 92270 or by fax to 760-773-4550.

disclosure

It is the policy of the Annenberg Center to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty and planners participating in sponsored programs are expected to identify and reference off-label product use and disclose any significant relationship with those supporting the activity or any others whose products or services are discussed.

In accordance with the Accreditation Council for Continuing Medical Education Standards, parallel documents from other accrediting bodies, and Annenberg Center policy, the following disclosures have been made:

Lance Parton, MD

Research Support Ovation Pharmaceuticals, Inc.

Consultant Ovation Pharmaceuticals, Inc.

Speakers Bureau DEY, LP; Ikaria, Inc.
Ovation Pharmaceuticals, Inc.

John York, PharmD (medical writer)

Consultant Alcon Laboratories
Cytogen
Ovation Pharmaceuticals, Inc.
Santen

All staff at the Annenberg Center for Health Sciences at Eisenhower have nothing to disclose.

The following faculty have no significant relationship to disclose:

Bart Van Overmeire, MD, PhD
Alan Picarillo, MD, FAAP

The faculty for this activity have disclosed that there will be discussion about the use of products for non-FDA approved indications.

The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient's unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.

This activity is an enduring material and consists of a web activity. Successful completion is achieved by reading and viewing the material, reflecting on its implications in your practice, and completing the assessment component.

The estimated time to complete the activity is 1 hour.

This activity was originally released in December 2008 and is eligible for credit through November 2009.

If you need reasonable, special accommodations or have questions about access to any of our activities, please contact Pam Davidson by phone: 800-321-3690, by fax: 760-773-4550, or by E-mail: .

This activity is supported by an unrestricted educational grant from Ovation Pharmaceuticals, Inc.